Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
about
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.Gene-environment interactions: key to unraveling the mystery of Parkinson's diseaseAbnormal differentiation of dopaminergic neurons in zebrafish trpm7 mutant larvae impairs development of the motor pattern.Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.Toxin-induced models of Parkinson's disease.Neuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model.Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.A guide to neurotoxic animal models of Parkinson's diseaseToxin models of mitochondrial dysfunction in Parkinson's disease.Mitochondrial DNA, base excision repair and neurodegeneration.Mouse models of mitochondrial complex I dysfunctionOxidative and nitrative protein modifications in Parkinson's diseaseGinsenosides: are any of them candidates for drugs acting on the central nervous system?A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchLessons from the rotenone model of Parkinson's disease.Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.A tale on animal models of Parkinson's disease.Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.SUMO and Parkinson's disease.Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Epigenetic regulation in Parkinson's disease.Targeting LRRK2 in Parkinson's disease: an update on recent developments.Neurobehavioural Changes in a Hemiparkinsonian Rat Model Induced by Rotenone.Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stressMutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis.Hypersusceptibility to chemicals: risk factors for neurological disease?1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats.Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine.1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons.
P2860
Q24815148-5F7AA05F-9C15-4721-86BE-B7E1F0507CD8Q26269955-120B5FFE-C69F-4A61-B076-15490EE94B0DQ28388674-5BC90D41-828C-44D0-97B0-D4EF2E8AE3A0Q30575217-D0251C95-7458-4680-9196-5588A7B85F2BQ33789328-7ECC9778-8A67-4BDF-8D63-5FCEC63DA9C6Q33844749-22B3F8FE-6372-43F4-8EC0-077C5D59A118Q34169019-8B00C44F-ABE8-4551-B3FD-131ED100FBCDQ34606427-503F6EC9-A023-4483-8082-C725209E0FEAQ35031643-1FC372CE-322D-40EE-B44B-7E29A3CBE6B4Q35551001-22E5FE42-4131-4A82-A988-51C6A8723D89Q35603488-89D7782B-885F-4A8F-96B9-0844ABD676C0Q35799141-960E7C3E-D1DC-4766-9D05-56DCC916F836Q36223869-FFE7F225-D78C-400D-8769-D570561E3A3FQ36428810-C6B89E46-DE3A-43BC-8E04-363CF1E0D4E6Q36710261-5E92623D-F2BB-471F-ABC5-04CC7F78F1FDQ37031566-B8CECC17-31E9-432E-B889-9D6C4A17BC7CQ37287403-7CD3B92F-3BDE-4B54-B68A-CD94F3DBD87DQ37680293-843C2FEB-8157-4D42-9A7A-BAE93BDE9D8EQ37698597-ED129493-C13E-4836-8562-1D0F20DA858CQ37882583-D35C53A5-7217-49DC-866A-C595D160A901Q37946305-834A9BCD-EBC1-4E0B-B8AF-C9C25292DB4DQ38009051-1DEF755A-1371-4A51-BF27-495030ED4F1EQ38074802-D7321AA1-DA23-4787-AD90-B63CCE6E33CDQ38131751-0961E81C-7108-469C-9EDA-73D1E3EB3ADDQ38295414-02D00695-D409-4E66-B49F-F85895235305Q38598375-5CE55F0B-52E6-48C0-9B9A-4387ACA9D2B0Q38881221-526FAE47-BB67-435C-A562-DB79EC5A2B2AQ39263032-8325B282-29F5-4F6B-AA74-8E58202D7670Q39311602-E27AB507-50F8-4D33-928E-AC364578F3C3Q39823008-64E8DFDA-8952-4956-BA0D-6FDD56C692FEQ39891449-19F0F3D4-DEE0-4F19-BF46-8623E28AAFF4Q39997806-4DF9A3F9-14B6-4C80-95FC-C23FF94E10F5Q41115413-EC0AA027-5B9D-41A1-8B18-A1C68183D5CEQ41142735-FECFBA17-FC3C-47D6-9EAE-C598840EE60CQ41386986-36FEDCA0-6F11-462D-B369-103A68DB1A37Q41722444-2714C28B-A7AD-45E0-B07B-77374FDE7FF0Q41741720-1BE400AE-CBF0-435A-AA1C-FEE4AD708855Q42112840-FA01BCC2-64A6-40EC-B6D9-8426B9149E49Q42871616-6F927B54-067D-4A45-B86A-7FA8A47690DEQ44163138-BC67A1A5-CA35-45DF-B857-104F51FFE64C
P2860
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@en
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@nl
type
label
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@en
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@nl
prefLabel
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@en
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@nl
P2093
P1433
P1476
Dopaminergic toxicity of roten ...... 6-tetrahydropyridine toxicity.
@en
P2093
P304
P356
10.1016/0304-3940(85)90580-4
P407
P577
1985-12-01T00:00:00Z